A novel lymphoma-associated macrophage interaction signature (LAMIS) provides robust risk prognostication in diffuse large B-cell lymphoma clinical trial cohorts of the DSHNHL
Leukemia, Published online: 17 September 2019; doi:10.1038/s41375-019-0573-yA novel lymphoma-associated macrophage interaction signature (LAMIS) provides robust risk prognostication in diffuse large B-cell lymphoma clinical trial cohorts of the DSHNHL (Source: Leukemia)
Source: Leukemia - September 17, 2019 Category: Hematology Authors: Annette M. Staiger Michael Altenbuchinger Marita Ziepert Christian Kohler Heike Horn Michael Huttner Katrin S. H üttl Gunther Glehr Wolfram Klapper Monika Szczepanowski Julia Richter Harald Stein Alfred C. Feller Peter M öller Martin-Leo Hansmann Viola Source Type: research

Treatment of relapsed or refractory classical Hodgkin lymphoma with the anti-PD-1, tislelizumab: results of a phase 2, single-arm, multicenter study
Leukemia, Published online: 13 September 2019; doi:10.1038/s41375-019-0545-2Treatment of relapsed or refractory classical Hodgkin lymphoma with the anti-PD-1, tislelizumab: results of a phase 2, single-arm, multicenter study (Source: Leukemia)
Source: Leukemia - September 13, 2019 Category: Hematology Authors: Yuqin Song Quanli Gao Huilai Zhang Lei Fan Jianfeng Zhou Dehui Zou Wei Li Haiyan Yang Ting Liu Quanshun Wang Fangfang Lv Haiyi Guo Liudi Yang Rebecca Elstrom Jane Huang William Novotny Vivian Wei Jun Zhu Source Type: research

Fusion driven JMML: a novel CCDC88C–FLT3 fusion responsive to sorafenib identified by RNA sequencing
Leukemia, Published online: 12 September 2019; doi:10.1038/s41375-019-0549-yFusion driven JMML: a novel CCDC88C–FLT3 fusion responsive to sorafenib identified by RNA sequencing (Source: Leukemia)
Source: Leukemia - September 12, 2019 Category: Hematology Authors: Alexander K. Chao Julia A. Meyer Alex G. Lee Anna Hecht Theodore Tarver Jessica Van Ziffle Ashley K. Koegel Carla Golden Benjamin S. Braun E. Alejandro Sweet-Cordero Catherine C. Smith Christopher C. Dvorak Mignon L. Loh Elliot Stieglitz Source Type: research

Clinicopathologic characteristics, prognostication and treatment outcomes for myelodysplastic/myeloproliferative neoplasm, unclassifiable (MDS/MPN-U): Mayo Clinic-Moffitt Cancer Center study of 135 consecutive patients
Leukemia, Published online: 11 September 2019; doi:10.1038/s41375-019-0574-xClinicopathologic characteristics, prognostication and treatment outcomes for myelodysplastic/myeloproliferative neoplasm, unclassifiable (MDS/MPN-U): Mayo Clinic-Moffitt Cancer Center study of 135 consecutive patients (Source: Leukemia)
Source: Leukemia - September 11, 2019 Category: Hematology Authors: Abhishek A. Mangaonkar David M. Swoboda Giacomo Coltro Terra L. Lasho Paul J. Novotny Prateek Pophali Ryan M. Carr Moritz Binder Christy M. Finke Naseema Gangat Aref Al-Kali Kebede H. Begna Kaaren K. Reichard Rhett P. Ketterling Najla H. Al Ali Pardis Vaf Source Type: research

Bone marrow mesenchymal stromal cells from acute myelogenous leukemia patients demonstrate adipogenic differentiation propensity with implications for leukemia cell support
Leukemia, Published online: 06 September 2019; doi:10.1038/s41375-019-0568-8Bone marrow mesenchymal stromal cells from acute myelogenous leukemia patients demonstrate adipogenic differentiation propensity with implications for leukemia cell support (Source: Leukemia)
Source: Leukemia - September 6, 2019 Category: Hematology Authors: Mitra Azadniv Jason R. Myers Helene R. McMurray Naxin Guo Phil Rock Myra L. Coppage John Ashton Michael W. Becker Laura M. Calvi Jane L. Liesveld Source Type: research

Inhibition of Slug effectively targets leukemia stem cells via the Slc13a3/ROS signaling pathway
Leukemia, Published online: 06 September 2019; doi:10.1038/s41375-019-0566-xInhibition of Slug effectively targets leukemia stem cells via the Slc13a3/ROS signaling pathway (Source: Leukemia)
Source: Leukemia - September 6, 2019 Category: Hematology Authors: Zhonghui Zhang Lei Li Chen Wu Guoshu Yin Pei Zhu Yalu Zhou Yuanfan Hong Hongyu Ni Zhijian Qian Wen-Shu Wu Source Type: research

Complete remission with incomplete count recovery (CRi) prior to allogeneic HCT for acute myeloid leukaemia is associated with a high non-relapse mortality
Leukemia, Published online: 02 September 2019; doi:10.1038/s41375-019-0572-zComplete remission with incomplete count recovery (CRi) prior to allogeneic HCT for acute myeloid leukaemia is associated with a high non-relapse mortality (Source: Leukemia)
Source: Leukemia - September 2, 2019 Category: Hematology Authors: Andrew J. Innes Philippa Woolley Richard M. Szydlo Sara Lozano Fiona Fernando Divya Bansal Renuka Palanicawandar Dragana Milojkovic Philippa C. May Elisabet Nadal-Melsio Eva Yebra-Fernandez Eduardo Olavarria Jane F. Apperley Ji ří Pavlů Source Type: research

Health-related quality of life of newly diagnosed chronic myeloid leukemia patients treated with first-line dasatinib versus imatinib therapy
Leukemia, Published online: 02 September 2019; doi:10.1038/s41375-019-0563-0Health-related quality of life of newly diagnosed chronic myeloid leukemia patients treated with first-line dasatinib versus imatinib therapy (Source: Leukemia)
Source: Leukemia - September 2, 2019 Category: Hematology Authors: Fabio Efficace Fabio Stagno Alessandra Iurlo Massimo Breccia Francesco Cottone Massimiliano Bonifacio Elisabetta Abruzzese Fausto Castagnetti Giovanni Caocci Monica Crugnola Isabella Capodanno Bruno Martino Mario Tiribelli Andrea Patriarca Antonella Gozzi Source Type: research

Knock-in of murine Calr del52 induces essential thrombocythemia with slow-rising dominance in mice and reveals key role of Calr exon 9 in cardiac development
Leukemia, Published online: 30 August 2019; doi:10.1038/s41375-019-0538-1Knock-in of murine Calr del52 induces essential thrombocythemia with slow-rising dominance in mice and reveals key role of Calr exon 9 in cardiac development (Source: Leukemia)
Source: Leukemia - August 30, 2019 Category: Hematology Authors: Thomas Balligand Younes Achouri Christian Pecquet Gilles Gaudray Didier Colau Eva Hug Yacine Rahmani Vincent Stroobant Isabelle Plo William Vainchenker Robert Kralovics Beno ît J. Van den Eynde Jean-Philippe Defour Stefan N. Constantinescu Source Type: research

An in vitro assay for biomarker discovery and dose prediction applied to ibrutinib plus venetoclax treatment of CLL
Leukemia, Published online: 30 August 2019; doi:10.1038/s41375-019-0569-7An in vitro assay for biomarker discovery and dose prediction applied to ibrutinib plus venetoclax treatment of CLL (Source: Leukemia)
Source: Leukemia - August 30, 2019 Category: Hematology Authors: Sigrid S. Sk ånland Andrea Cremaschi Henrik Bendiksen Johanne U. Hermansen Deepak B. Thimiri Govinda Raj Ludvig A. Munthe Geir E. Tj ønnfjord Kjetil Task én Source Type: research

Bidirectional linkage between the B-cell receptor and NOTCH1 in chronic lymphocytic leukemia and in Richter’s syndrome: therapeutic implications
Leukemia, Published online: 29 August 2019; doi:10.1038/s41375-019-0571-0Bidirectional linkage between the B-cell receptor and NOTCH1 in chronic lymphocytic leukemia and in Richter’s syndrome: therapeutic implications (Source: Leukemia)
Source: Leukemia - August 29, 2019 Category: Hematology Authors: Francesca Arruga Valeria Bracciam à Nicoletta Vitale Tiziana Vaisitti Katiuscia Gizzi Alison Yeomans Marta Coscia Giovanni D ’Arena Gianluca Gaidano John N. Allan Richard R. Furman Graham Packham Francesco Forconi Silvia Deaglio Source Type: research

Carfilzomib-induced reticulocytosis in patients with multiple myeloma is caused by impaired terminal erythroid maturation
Leukemia, Published online: 29 August 2019; doi:10.1038/s41375-019-0565-yCarfilzomib-induced reticulocytosis in patients with multiple myeloma is caused by impaired terminal erythroid maturation (Source: Leukemia)
Source: Leukemia - August 29, 2019 Category: Hematology Authors: Nicolas G. Kint Elien Heylen Daniele Pepe Kim De Keersmaecker Catherine M. Verfaillie Michel Delforge Source Type: research

MRD response in relapsed/refractory FL after obinutuzumab plus bendamustine or bendamustine alone in the GADOLIN trial
Leukemia, Published online: 28 August 2019; doi:10.1038/s41375-019-0559-9MRD response in relapsed/refractory FL after obinutuzumab plus bendamustine or bendamustine alone in the GADOLIN trial (Source: Leukemia)
Source: Leukemia - August 28, 2019 Category: Hematology Authors: Christiane Pott Laurie H. Sehn David Belada John Gribben Eva Hoster Brad Kahl Britta Kehden Emmanuelle Nicolas-Virelizier Nathalie Spielewoy Guenter Fingerle-Rowson Chris Harbron Kirsten Mundt Elisabeth Wassner-Fritsch Bruce D. Cheson Source Type: research

Mutant calreticulin interacts with MPL in the secretion pathway for activation on the cell surface
Leukemia, Published online: 28 August 2019; doi:10.1038/s41375-019-0564-zMutant calreticulin interacts with MPL in the secretion pathway for activation on the cell surface (Source: Leukemia)
Source: Leukemia - August 28, 2019 Category: Hematology Authors: Nami Masubuchi Marito Araki Yinjie Yang Erina Hayashi Misa Imai Yoko Edahiro Yumi Hironaka Yoshihisa Mizukami Yoshihiko Kihara Hiraku Takei Mai Nudejima Masato Koike Akimichi Ohsaka Norio Komatsu Source Type: research

BCR signaling contributes to autophagy regulation in chronic lymphocytic leukemia
Leukemia, Published online: 28 August 2019; doi:10.1038/s41375-019-0557-yBCR signaling contributes to autophagy regulation in chronic lymphocytic leukemia (Source: Leukemia)
Source: Leukemia - August 28, 2019 Category: Hematology Authors: Lindsay D. Smith Annabel R. Minton Matthew D. Blunt Laura I. Karydis David A. Dutton Karly-Rai Rogers-Broadway Rachel Dobson Rena Liu Faith Norster Elizabeth Hogg Margaret Ashton-Key Jonathan C. Strefford Li Jia Dimitar G. Efremov G. Vignir Helgason Peter Source Type: research

Altered expression of CSF3R splice variants impacts signal response and is associated with SRSF2 mutations
Leukemia, Published online: 28 August 2019; doi:10.1038/s41375-019-0567-9Altered expression of CSF3R splice variants impacts signal response and is associated with SRSF2 mutations (Source: Leukemia)
Source: Leukemia - August 28, 2019 Category: Hematology Authors: Amanda Lance Lawrence J. Druhan C. Greer Vestal Nury M. Steuerwald Alicia Hamilton Mathew Smith Andrea Price Elise Tjaden Andee N. Fox Belinda R. Avalos Source Type: research

PI3K-p110δ contributes to antibody responses by macrophages in chronic lymphocytic leukemia
Leukemia, Published online: 28 August 2019; doi:10.1038/s41375-019-0556-zPI3K-p110δ contributes to antibody responses by macrophages in chronic lymphocytic leukemia (Source: Leukemia)
Source: Leukemia - August 28, 2019 Category: Hematology Authors: Yu-Chen Enya Chen Melinda Burgess Sally Mapp Peter Mollee Devinder Gill Antje Blumenthal Nicholas A. Saunders Source Type: research

Functional and clinical characterization of the alternatively spliced isoform AML1-ETO9a in adult patients with translocation t(8;21)(q22;q22.1) acute myeloid leukemia (AML)
Leukemia, Published online: 28 August 2019; doi:10.1038/s41375-019-0551-4Functional and clinical characterization of the alternatively spliced isoform AML1-ETO9a in adult patients with translocation t(8;21)(q22;q22.1) acute myeloid leukemia (AML) (Source: Leukemia)
Source: Leukemia - August 28, 2019 Category: Hematology Authors: Mridul Agrawal Peggy Schwarz Benedetto Daniele Giaimo Ivan Bedzhov Andrea Corbacioglu Daniela Weber Verena I. Gaidzik Nikolaus Jahn Frank G. R ücker Thomas Schroeder Thomas Kindler Mohammed Wattad Katharina G ötze Michael L übbert Hans Salwender Mark R Source Type: research

Allogeneic transplantation in multiple myeloma: long-term follow-up and cytogenetic subgroup analysis
Leukemia, Published online: 28 August 2019; doi:10.1038/s41375-019-0537-2Allogeneic transplantation in multiple myeloma: long-term follow-up and cytogenetic subgroup analysis (Source: Leukemia)
Source: Leukemia - August 28, 2019 Category: Hematology Authors: Stefan Knop Monika Engelhardt Peter Liebisch Christoph Meisner Ernst Holler Bernd Metzner Dietrich Peest Martin Kaufmann Donald Bunjes Christian Straka Thomas Fischer Orhan Sezer Marcus Hentrich Helmut Ostermann Florian Bassermann Georg Hess Bernd Hertens Source Type: research

Clinical and molecular characterization of patients with acute myeloid leukemia and sole trisomies of chromosomes 4, 8, 11, 13 or 21
Leukemia, Published online: 28 August 2019; doi:10.1038/s41375-019-0560-3Clinical and molecular characterization of patients with acute myeloid leukemia and sole trisomies of chromosomes 4, 8, 11, 13 or 21 (Source: Leukemia)
Source: Leukemia - August 28, 2019 Category: Hematology Authors: Bhavana Bhatnagar Ann-Kathrin Eisfeld Jessica Kohlschmidt Krzysztof Mr ózek Deedra Nicolet Dimitrios Papaioannou Christopher J. Walker Shelley Orwick James S. Blachly Jonathan E. Kolitz Bayard L. Powell Andrew J. Carroll Richard M. Stone John C. Byrd Cla Source Type: research

Chronic myeloid leukemia: the concepts of resistance and persistence and the relationship with the BCR-ABL1 transcript type
Leukemia, Published online: 27 August 2019; doi:10.1038/s41375-019-0562-1Chronic myeloid leukemia: the concepts of resistance and persistence and the relationship with the BCR-ABL1 transcript type (Source: Leukemia)
Source: Leukemia - August 27, 2019 Category: Hematology Authors: Michele Baccarani Gianantonio Rosti Simona Soverini Source Type: research

Evaluation of ERK as a therapeutic target in acute myelogenous leukemia
Leukemia, Published online: 27 August 2019; doi:10.1038/s41375-019-0552-3Evaluation of ERK as a therapeutic target in acute myelogenous leukemia (Source: Leukemia)
Source: Leukemia - August 27, 2019 Category: Hematology Authors: Ellen Weisberg Chengcheng Meng Abigail Case Martin Sattler Hong L. Tiv Prafulla C. Gokhale Sara Buhrlage Jinhua Wang Nathanael Gray Richard Stone Suiyang Liu Shripad V. Bhagwat Ramon V. Tiu Sophia Adamia James D. Griffin Source Type: research

Relapsed refractory multiple myeloma: a comprehensive overview
Leukemia, Published online: 27 August 2019; doi:10.1038/s41375-019-0561-2Relapsed refractory multiple myeloma: a comprehensive overview (Source: Leukemia)
Source: Leukemia - August 27, 2019 Category: Hematology Authors: Abdul Hamid Bazarbachi Rama Al Hamed Florent Malard Jean-Luc Harousseau Mohamad Mohty Source Type: research

Obinutuzumab plus fludarabine and cyclophosphamide in previously untreated, fit patients with chronic lymphocytic leukemia: a subgroup analysis of the GREEN study
Leukemia, Published online: 27 August 2019; doi:10.1038/s41375-019-0554-1Obinutuzumab plus fludarabine and cyclophosphamide in previously untreated, fit patients with chronic lymphocytic leukemia: a subgroup analysis of the GREEN study (Source: Leukemia)
Source: Leukemia - August 27, 2019 Category: Hematology Authors: Francesc Bosch Guy Cantin Agostino Cortelezzi Wolfgang Knauf Mourad Tiab Mehmet Turgut Andrey Zaritskey Jean-Louis Merot Eugen Tausch Kerstin Trunzer Susan Robson Ekaterina Gresko Sebastian B öttcher Robin Fo à Stephan Stilgenbauer V éronique Leblond Source Type: research

TP53 deficiency permits chromosome abnormalities and karyotype heterogeneity in acute myeloid leukemia
Leukemia, Published online: 23 August 2019; doi:10.1038/s41375-019-0550-5TP53 deficiency permits chromosome abnormalities and karyotype heterogeneity in acute myeloid leukemia (Source: Leukemia)
Source: Leukemia - August 23, 2019 Category: Hematology Authors: Anna Cazzola Christin Schlegel Ilka Jansen Tilmann Bochtler Anna Jauch Alwin Kr ämer Source Type: research

New anti-IL-7Rα monoclonal antibodies show efficacy against T cell acute lymphoblastic leukemia in pre-clinical models
Leukemia, Published online: 22 August 2019; doi:10.1038/s41375-019-0531-8New anti-IL-7Rα monoclonal antibodies show efficacy against T cell acute lymphoblastic leukemia in pre-clinical models (Source: Leukemia)
Source: Leukemia - August 22, 2019 Category: Hematology Authors: Julie A. Hixon Caroline Andrews Lila Kashi Casey L. Kohnhorst Emilee Senkevitch Kelli Czarra Joao T. Barata Wenqing Li Joel P. Schneider Scott T. R. Walsh Scott K. Durum Source Type: research

MYC dysregulation in the progression of multiple myeloma
Leukemia, Published online: 22 August 2019; doi:10.1038/s41375-019-0543-4MYC dysregulation in the progression of multiple myeloma (Source: Leukemia)
Source: Leukemia - August 22, 2019 Category: Hematology Authors: Kristine Misund Niamh Keane Caleb K. Stein Yan W. Asmann Grady Day Seth Welsh Scott A. Van Wier Daniel L. Riggs Greg Ahmann Marta Chesi David S. Viswanatha Shaji K. Kumar Angela Dispenzieri Veronica Gonzalez-Calle Robert A. Kyle Michael O ’Dwyer S. Vinc Source Type: research

Dynamic CD138 surface expression regulates switch between myeloma growth and dissemination
Leukemia, Published online: 22 August 2019; doi:10.1038/s41375-019-0519-4Dynamic CD138 surface expression regulates switch between myeloma growth and dissemination (Source: Leukemia)
Source: Leukemia - August 22, 2019 Category: Hematology Authors: Ilseyar Akhmetzyanova Mark J. McCarron Samir Parekh Marta Chesi P. Leif Bergsagel David R. Fooksman Source Type: research

Specific gut microbiota changes heralding bloodstream infection and neutropenic fever during intensive chemotherapy
Leukemia, Published online: 22 August 2019; doi:10.1038/s41375-019-0547-0Specific gut microbiota changes heralding bloodstream infection and neutropenic fever during intensive chemotherapy (Source: Leukemia)
Source: Leukemia - August 22, 2019 Category: Hematology Authors: Armin Rashidi Thomas Kaiser Carolyn Graiziger Shernan G. Holtan Tauseef Ur Rehman Daniel J. Weisdorf Alexander Khoruts Christopher Staley Source Type: research

Second primary malignancies in myeloproliferative neoplasms and the role of aspirin
Leukemia, Published online: 21 August 2019; doi:10.1038/s41375-019-0553-2Second primary malignancies in myeloproliferative neoplasms and the role of aspirin (Source: Leukemia)
Source: Leukemia - August 21, 2019 Category: Hematology Authors: Marko Lucijanic Marko Skelin Rajko Kusec Source Type: research

Cryptic genomic lesions in adverse-risk acute myeloid leukemia identified by integrated whole genome and transcriptome sequencing
Leukemia, Published online: 21 August 2019; doi:10.1038/s41375-019-0546-1Cryptic genomic lesions in adverse-risk acute myeloid leukemia identified by integrated whole genome and transcriptome sequencing (Source: Leukemia)
Source: Leukemia - August 21, 2019 Category: Hematology Authors: Jaeseung C. Kim Philip C. Zuzarte Tracy Murphy Michelle Chan-Seng-Yue Andrew M. K. Brown Paul M. Krzyzanowski Adam C. Smith Faiyaz Notta Mark D. Minden John D. McPherson Source Type: research

Daratumumab for eradication of minimal residual disease in high-risk advanced relapse of T-cell/CD19/CD22-negative acute lymphoblastic leukemia
Leukemia, Published online: 21 August 2019; doi:10.1038/s41375-019-0548-zDaratumumab for eradication of minimal residual disease in high-risk advanced relapse of T-cell/CD19/CD22-negative acute lymphoblastic leukemia (Source: Leukemia)
Source: Leukemia - August 21, 2019 Category: Hematology Authors: Yishai Ofran Shimrit Ringelstein-Harlev Ilana Slouzkey Tsila Zuckerman Dana Yehudai-Ofir Israel Henig Ofrat Beyar-Katz Michal Hayun Avraham Frisch Source Type: research

Genotyping circulating tumor DNA of pediatric Hodgkin lymphoma
Leukemia, Published online: 20 August 2019; doi:10.1038/s41375-019-0541-6Genotyping circulating tumor DNA of pediatric Hodgkin lymphoma (Source: Leukemia)
Source: Leukemia - August 20, 2019 Category: Hematology Authors: Ann-Kathrin Desch Kristin Hartung Ante Botzen Alexander Brobeil Mathias Rummel Lars Kurch Thomas Georgi Theresa Jox Stefan Bielack Stefan Burdach Carl Friedrich Classen Alexander Claviez Klaus-Michael Debatin Martin Ebinger Angelika Eggert J örg Faber Ch Source Type: research

Leukemia evolving from paroxysmal nocturnal hemoglobinuria
Leukemia, Published online: 20 August 2019; doi:10.1038/s41375-019-0555-0Leukemia evolving from paroxysmal nocturnal hemoglobinuria (Source: Leukemia)
Source: Leukemia - August 20, 2019 Category: Hematology Authors: Hassan Awada Shafia Rahman Jibran Durrani Mohammad F. Asad Cassandra M. Kerr Vera Adema Ashwin Kishtagari Amy Graham Christina A. Snider Sunisa Kongkiatkamon Yasunobu Nagata Bhumika J. Patel Hetty E. Carraway Mikkael A. Sekeres Jaroslaw P. Maciejewski Val Source Type: research

A simplified frailty scale predicts outcomes in transplant-ineligible patients with newly diagnosed multiple myeloma treated in the FIRST (MM-020) trial
Leukemia, Published online: 19 August 2019; doi:10.1038/s41375-019-0539-0A simplified frailty scale predicts outcomes in transplant-ineligible patients with newly diagnosed multiple myeloma treated in the FIRST (MM-020) trial (Source: Leukemia)
Source: Leukemia - August 19, 2019 Category: Hematology Authors: Thierry Facon Meletios A. Dimopoulos Nathalie Meuleman Andrew Belch Mohamad Mohty Wen-Ming Chen Kihyun Kim Elena Zamagni Paula Rodriguez-Otero William Renwick Christian Rose Adrian Tempescul Eileen Boyle Salomon Manier Michel Attal Philippe Moreau Margare Source Type: research

BCMA peptide-engineered nanoparticles enhance induction and function of antigen-specific CD8+ cytotoxic T lymphocytes against multiple myeloma: clinical applications
Leukemia, Published online: 19 August 2019; doi:10.1038/s41375-019-0540-7BCMA peptide-engineered nanoparticles enhance induction and function of antigen-specific CD8+ cytotoxic T lymphocytes against multiple myeloma: clinical applications (Source: Leukemia)
Source: Leukemia - August 19, 2019 Category: Hematology Authors: Jooeun Bae Neha Parayath Wenxue Ma Mansoor Amiji Nikhil Munshi Kenneth Anderson Source Type: research

The impact of complex karyotype on the overall survival of patients with relapsed chronic lymphocytic leukemia treated with idelalisib plus rituximab
Leukemia, Published online: 19 August 2019; doi:10.1038/s41375-019-0533-6The impact of complex karyotype on the overall survival of patients with relapsed chronic lymphocytic leukemia treated with idelalisib plus rituximab (Source: Leukemia)
Source: Leukemia - August 19, 2019 Category: Hematology Authors: Karl-Anton Kreuzer Richard R. Furman Stephan Stilgenbauer Ronald L. Dubowy Yeonhee Kim Veerendra Munugalavadla Esther Lilienweiss Hans Christian Reinhardt Paula Cramer Barbara Eichhorst Peter Hillmen Susan M. O ’Brien Andrew R. Pettitt Michael Hallek Source Type: research

Long non-coding RNA NEAT1 targeting impairs the DNA repair machinery and triggers anti-tumor activity in multiple myeloma
Leukemia, Published online: 19 August 2019; doi:10.1038/s41375-019-0542-5Long non-coding RNA NEAT1 targeting impairs the DNA repair machinery and triggers anti-tumor activity in multiple myeloma (Source: Leukemia)
Source: Leukemia - August 19, 2019 Category: Hematology Authors: Elisa Taiana Vanessa Favasuli Domenica Ronchetti Katia Todoerti Francesca Pelizzoni Martina Manzoni Marzia Barbieri Sonia Fabris Ilaria Silvestris Maria Eugenia Gallo Cantafio Natalia Platonova Valeria Zuccal à Lorenza Maltese Debora Soncini Samantha Rub Source Type: research

Haploidentical vs. unrelated allogeneic stem cell transplantation for acute lymphoblastic leukemia in first complete remission: on behalf of the ALWP of the EBMT
Leukemia, Published online: 19 August 2019; doi:10.1038/s41375-019-0544-3Haploidentical vs. unrelated allogeneic stem cell transplantation for acute lymphoblastic leukemia in first complete remission: on behalf of the ALWP of the EBMT (Source: Leukemia)
Source: Leukemia - August 19, 2019 Category: Hematology Authors: Noga Shem-Tov Christophe Peczynski Myriam Labopin Maija It älä-Remes Didier Blaise H élène Labussière-Wallet Gerard Soci é Nicolaus Kr öger Stephan Mielke Boris Afanasyev Patrice Chevallier Johanna Tischer Grzegorz Helbig Pavel Jindra Zinaida Peric Source Type: research

Prognostic factors for adult single cord blood transplantation among European and Japanese populations: the Eurocord/ALWP-EBMT and JSHCT/JDCHCT collaborative study
Leukemia, Published online: 14 August 2019; doi:10.1038/s41375-019-0534-5Prognostic factors for adult single cord blood transplantation among European and Japanese populations: the Eurocord/ALWP-EBMT and JSHCT/JDCHCT collaborative study (Source: Leukemia)
Source: Leukemia - August 14, 2019 Category: Hematology Authors: Junya Kanda Hiromi Hayashi Annalisa Ruggeri Fumihiko Kimura Fernanda Volt Satoshi Takahashi Myriam Labopin Shinichi Kako Karina Tozatto-Maio Shingo Yano Guillermo Sanz Naoyuki Uchida Maria Teresa Van Lint Seiko Kato Mohamad Mohty Edouard Forcade Heiwa Kan Source Type: research

In vivo vaccination effect in multiple myeloma patients treated with the monoclonal antibody isatuximab
Leukemia, Published online: 13 August 2019; doi:10.1038/s41375-019-0536-3In vivo vaccination effect in multiple myeloma patients treated with the monoclonal antibody isatuximab (Source: Leukemia)
Source: Leukemia - August 13, 2019 Category: Hematology Authors: Djordje Atanackovic Sara Yousef Christa Shorter Srinivas K. Tantravahi Mary Steinbach Fiorella Iglesias Douglas Sborov Sabarinath Venniyil Radhakrishnan Marielle Chiron Rodney Miles Mohamed Salama Nicolaus Kr öger Tim Luetkens Source Type: research

Integrative phosphoproteome and interactome analysis of the role of Ubash3b in BCR-ABL signaling
Leukemia, Published online: 09 August 2019; doi:10.1038/s41375-019-0535-4Integrative phosphoproteome and interactome analysis of the role of Ubash3b in BCR-ABL signaling (Source: Leukemia)
Source: Leukemia - August 9, 2019 Category: Hematology Authors: Jevon A. Cutler Savita Udainiya Anil K. Madugundu Santosh Renuse Yaoyu Xu Jaehun Jung Kwang Pyo Kim Xinyan Wu Akhilesh Pandey Source Type: research

A three-dimensional in vitro model of erythropoiesis recapitulates erythroid failure in myelodysplastic syndromes
Leukemia, Published online: 02 August 2019; doi:10.1038/s41375-019-0532-7A three-dimensional in vitro model of erythropoiesis recapitulates erythroid failure in myelodysplastic syndromes (Source: Leukemia)
Source: Leukemia - August 2, 2019 Category: Hematology Authors: Edda Mar ía Elvarsdóttir Teresa Mortera-Blanco Marios Dimitriou Thibault Bouderlique Monika Jansson Isabel Juliana F. Hofman Simona Conte Mohsen Karimi Birgitta Sander Iyadh Douagi Petter S. Woll Eva Hellstr öm-Lindberg Source Type: research

Allogeneic haemopoietic transplantation for acute myeloid leukaemia in second complete remission: a registry report by the Acute Leukaemia Working Party of the EBMT
Leukemia, Published online: 30 July 2019; doi:10.1038/s41375-019-0527-4Allogeneic haemopoietic transplantation for acute myeloid leukaemia in second complete remission: a registry report by the Acute Leukaemia Working Party of the EBMT (Source: Leukemia)
Source: Leukemia - July 30, 2019 Category: Hematology Authors: Maria H. Gilleece Myriam Labopin Bipin N. Savani Ibrahim Yakoub-Agha Gerard Soci é Tobias Gedde-Dahl Didier Blaise Jennifer L. Byrne Charles Craddock Jan J. Cornelissen William Arcese Edouard Forcade Charles Crawley Emmanuelle Polge Mohamad Mohty Arnon N Source Type: research

A prospective evaluation of pegylated interferon alfa-2a therapy in patients with polycythemia vera and essential thrombocythemia with a prior splanchnic vein thrombosis
Leukemia, Published online: 30 July 2019; doi:10.1038/s41375-019-0524-7A prospective evaluation of pegylated interferon alfa-2a therapy in patients with polycythemia vera and essential thrombocythemia with a prior splanchnic vein thrombosis (Source: Leukemia)
Source: Leukemia - July 30, 2019 Category: Hematology Authors: J. Mascarenhas H. Kosiorek J. Prchal A. Yacoub D. Berenzon M. R. Baer E. Ritchie R. T. Silver C. Kessler E. Winton M. C. Finazzi A. Rambaldi A. M. Vannucchi D. Leibowitz D. Rondelli M. O. Arcasoy R. Catchatourian J. Vadakara V. Rosti E. Hexner M. Kremyans Source Type: research

The novel autophagy inhibitor ROC-325 augments the antileukemic activity of azacitidine
Leukemia, Published online: 29 July 2019; doi:10.1038/s41375-019-0529-2The novel autophagy inhibitor ROC-325 augments the antileukemic activity of azacitidine (Source: Leukemia)
Source: Leukemia - July 29, 2019 Category: Hematology Authors: Steffan T. Nawrocki Yingchun Han Valeria Visconte Bartlomiej Przychodzen Claudia M. Espitia James Phillips Faiz Anwer Anjali Advani Hetty E. Carraway Kevin R. Kelly Mikkael A. Sekeres Jaroslaw P. Maciejewski Jennifer S. Carew Source Type: research

Soluble SLAMF7 promotes the growth of myeloma cells via homophilic interaction with surface SLAMF7
Leukemia, Published online: 29 July 2019; doi:10.1038/s41375-019-0525-6Soluble SLAMF7 promotes the growth of myeloma cells via homophilic interaction with surface SLAMF7 (Source: Leukemia)
Source: Leukemia - July 29, 2019 Category: Hematology Authors: Jiro Kikuchi Mitsuo Hori Hidekatsu Iha Noriko Toyama-Sorimachi Shotaro Hagiwara Yoshiaki Kuroda Daisuke Koyama Tohru Izumi Hiroshi Yasui Atsushi Suzuki Yusuke Furukawa Source Type: research

Novel evidence that an alternative complement cascade pathway is involved in optimal mobilization of hematopoietic stem/progenitor cells in Nlrp3 inflammasome-dependent manner
Leukemia, Published online: 26 July 2019; doi:10.1038/s41375-019-0530-9Novel evidence that an alternative complement cascade pathway is involved in optimal mobilization of hematopoietic stem/progenitor cells in Nlrp3 inflammasome-dependent manner (Source: Leukemia)
Source: Leukemia - July 26, 2019 Category: Hematology Authors: Mateusz Adamiak Anna M. Lenkiewicz Monika Cymer Magda Kucia Janina Ratajczak Mariusz Z. Ratajczak Source Type: research

TP53 abnormalities and chromosomal aneuploidy in acute panmyelosis with myelofibrosis
Leukemia, Published online: 26 July 2019; doi:10.1038/s41375-019-0523-8TP53 abnormalities and chromosomal aneuploidy in acute panmyelosis with myelofibrosis (Source: Leukemia)
Source: Leukemia - July 26, 2019 Category: Hematology Authors: Milena Pantic Dietmar Pfeifer Silke Kapp-Schwoerer Gabriele Ihorst Heiko Becker Robert Zeiser Justus Duyster Annette Schmitt-Graeff Source Type: research

Phorbol ester induced ex vivo expansion of rigorously-defined phenotypic but not functional human cord blood hematopoietic stem cells: a cautionary tale demonstrating that phenotype does not always recapitulate stem cell function
Leukemia, Published online: 26 July 2019; doi:10.1038/s41375-019-0528-3Phorbol ester induced ex vivo expansion of rigorously-defined phenotypic but not functional human cord blood hematopoietic stem cells: a cautionary tale demonstrating that phenotype does not always recapitulate stem cell function (Source: Leukemia)
Source: Leukemia - July 26, 2019 Category: Hematology Authors: Yandan Chen Chunxu Yao Yincheng Teng Rongzhen Jiang Xinxin Huang Sheng Liu Jun Wan Hal E. Broxmeyer Bin Guo Source Type: research